{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:22:53Z","timestamp":1777983773272,"version":"3.51.4"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","award":["RFO funding scheme"],"award-info":[{"award-number":["RFO funding scheme"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","award":["RFO funding scheme"],"award-info":[{"award-number":["RFO funding scheme"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","award":["RFO funding scheme"],"award-info":[{"award-number":["RFO funding scheme"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44934-2","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:46:50Z","timestamp":1774633610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Albumin-on-a-chip: binding profiling of circulating human albumin via selective immunocapture and real-time SPR analysis"],"prefix":"10.1038","volume":"16","author":[{"given":"Marta","family":"Nugnes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2890-3856","authenticated-orcid":false,"given":"Marina","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4468-2974","authenticated-orcid":false,"given":"Manuela","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"44934_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"41","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan, G. J., Martin, G. S. & Evans, T. W. Albumin: Biochemical properties and therapeutic potential. Hepatology 41, 1211\u20131219 (2005).","journal-title":"Hepatology"},{"key":"44934_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.molstruc.2013.09.053","volume":"1077","author":"P Ascenzi","year":"2014","unstructured":"Ascenzi, P., Fanali, G., Fasano, M., Pallottini, V. & Trezza, V. Clinical relevance of drug binding to plasma proteins q. J. Mol. Struct. 1077, 4\u201313 (2014).","journal-title":"J. Mol. Struct."},{"key":"44934_CR3","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/15216540500404093","volume":"57","author":"M Fasano","year":"2005","unstructured":"Fasano, M. et al. The extraordinary ligand binding properties of human serum albumin. IUBMB Life. 57, 787\u2013796 (2005).","journal-title":"IUBMB Life"},{"key":"44934_CR4","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0026-895X(25)10855-9","volume":"12","author":"G Sudlow","year":"1976","unstructured":"Sudlow, G., Birkett, D. J. & Wade, D. N. Further characterization of specific drug binding sites on human serum albumin. Mol. Pharmacol. 12, 1052\u20131061 (1976).","journal-title":"Mol. Pharmacol."},{"key":"44934_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S0026-895X(25)10691-3","volume":"11","author":"G Sudlow","year":"1975","unstructured":"Sudlow, G., Birkett, D. J. & Wade, D. N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11, 824\u2013832 (1975).","journal-title":"Mol. Pharmacol."},{"key":"44934_CR6","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1021\/mp400027q","volume":"10","author":"F Zsila","year":"2013","unstructured":"Zsila, F. Subdomain IB is the third major drug binding region of human serum albumin: Toward the three-sites model. Mol. Pharm. 10, 1668\u20131682 (2013).","journal-title":"Mol. Pharm."},{"key":"44934_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","volume":"353","author":"J Ghuman","year":"2005","unstructured":"Ghuman, J. et al. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353, 38\u201352 (2005).","journal-title":"J. Mol. Biol."},{"key":"44934_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","volume":"33","author":"G Fanali","year":"2012","unstructured":"Fanali, G. et al. Human serum albumin: From bench to bedside. Mol. Aspects Med. 33, 209\u2013290 (2012).","journal-title":"Mol. Aspects Med."},{"key":"44934_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-62341-z","volume":"10","author":"S Paramasivan","year":"2020","unstructured":"Paramasivan, S. et al. Serum albumin cysteine trioxidation is a potential oxidative stress biomarker of type 2 diabetes mellitus. Sci. Rep. 10, 1\u201312 (2020).","journal-title":"Sci. Rep."},{"key":"44934_CR10","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1248\/bpb.b22-00586","volume":"45","author":"H Watanabe","year":"2022","unstructured":"Watanabe, H. Oxidized albumin: Evaluation of oxidative stress as a marker for the progression of kidney disease. Biol. Pharm. Bull. 45, 1728\u20131732 (2022).","journal-title":"Biol. Pharm. Bull."},{"key":"44934_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.27322","volume":"60","author":"M Domenicali","year":"2014","unstructured":"Domenicali, M. et al. Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis. Hepatology 60, 1851\u20131860 (2014).","journal-title":"Hepatology"},{"key":"44934_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.bbagen.2003.08.001","volume":"1623","author":"K Nakajou","year":"2003","unstructured":"Nakajou, K., Watanabe, H., Kragh-Hansen, U., Maruyama, T. & Otagiri, M. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochim. Biophys. Acta - Gen. Subj. 1623, 88\u201397 (2003).","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"44934_CR13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2337\/db19-0738","volume":"69","author":"H Qiu","year":"2020","unstructured":"Qiu, H. et al. Comprehensive glycomic analysis reveals that human serum albumin glycation specifically affects the pharmacokinetics and efficacy of different anticoagulant drugs in diabetes. Diabetes 69, 760\u2013770 (2020).","journal-title":"Diabetes"},{"key":"44934_CR14","first-page":"214","volume":"22","author":"AC Fender","year":"2019","unstructured":"Fender, A. C. & Dobrev, D. Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome. IJC Hear. Vasc. 22, 214\u2013215 (2019).","journal-title":"IJC Hear. Vasc"},{"key":"44934_CR15","first-page":"2868","volume":"19","author":"L Bertozo","year":"2018","unstructured":"Bertozo, L., de Neto, C. T., de Oliveira, E., Ximenes, V. F. & L. C. & Oxidative alteration of Trp-214 and Lys-199 in human serum albumin increases binding affinity with phenylbutazone: A combined experimental and computational investigation. Int. J. Mol. Sci. 2018. 19, 2868 (2018).","journal-title":"Int. J. Mol. Sci. 2018"},{"key":"44934_CR16","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/jssc.201600713","volume":"39","author":"L Michalcov\u00e1","year":"2016","unstructured":"Michalcov\u00e1, L. & Glatz, Z. Study on the interactions of sulfonylurea antidiabetic drugs with normal and glycated human serum albumin by capillary electrophoresis-frontal analysis. J. Sep. Sci. 39, 3631\u20133637 (2016).","journal-title":"J. Sep. Sci."},{"key":"44934_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jpba.2010.04.035","volume":"53","author":"KSS Joseph","year":"2010","unstructured":"Joseph, K. S. S. & Hage, D. S. The effects of glycation on the binding of human serum albumin to warfarin and l-tryptophan. J. Pharm. Biomed. Anal. 53, 811\u2013818 (2010).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"44934_CR18","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1016\/S0021-9258(19)85847-7","volume":"255","author":"J Wilting","year":"1980","unstructured":"Wilting, J. et al. The effect of albumin conformation on the binding of warfarin to human serum albumin. The dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium, and chloride ion concentrations as studied by circular dichroism, fluorescence. J. Biol. Chem. 255, 3032\u20133037 (1980).","journal-title":"J. Biol. Chem."},{"key":"44934_CR19","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1172\/JCI103742","volume":"37","author":"DS Fredrickson","year":"1958","unstructured":"Fredrickson, D. S. & Gordon, R. S. The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects. J. Clin. Invest. 37, 1504\u20131515 (1958).","journal-title":"J. Clin. Invest."},{"key":"44934_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02269-w","volume":"4","author":"M Paar","year":"2021","unstructured":"Paar, M. et al. Albumin in patients with liver disease shows an altered conformation. Commun. Biol. 4, 1\u20139 (2021).","journal-title":"Commun. Biol."},{"key":"44934_CR21","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/j.biochi.2012.05.017","volume":"94","author":"J Baraka-Vidot","year":"2012","unstructured":"Baraka-Vidot, J., Guerin-Dubourg, A., Bourdon, E. & Rondeau, P. Impaired drug-binding capacities of in vitro and in vivo glycated albumin. Biochimie 94, 1960\u20131967 (2012).","journal-title":"Biochimie"},{"key":"44934_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","volume":"59","author":"K Oettl","year":"2013","unstructured":"Oettl, K. et al. Oxidative albumin damage in chronic liver failure: Relation to albumin binding capacity, liver dysfunction and survival. J. Hepatol. 59, 978\u2013983 (2013).","journal-title":"J. Hepatol."},{"key":"44934_CR23","doi-asserted-by":"publisher","first-page":"e85216","DOI":"10.1371\/journal.pone.0085216","volume":"9","author":"K Nagumo","year":"2014","unstructured":"Nagumo, K. et al. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases. PLoS One. 9, e85216 (2014).","journal-title":"PLoS One"},{"key":"44934_CR24","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2337\/db14-0879","volume":"64","author":"D Blache","year":"2015","unstructured":"Blache, D. et al. Glycated albumin with loss of fatty acid binding capacity contributes to enhanced arachidonate oxygenation and platelet hyperactivity: Relevance in patients with type 2 diabetes. Diabetes 64, 960\u2013972 (2015).","journal-title":"Diabetes"},{"key":"44934_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/acssensors.6b00763","volume":"2","author":"JF Masson","year":"2017","unstructured":"Masson, J. F. Surface plasmon resonance clinical biosensors for medical diagnostics. ACS Sens. 2, 16\u201330 (2017).","journal-title":"ACS Sens."},{"key":"44934_CR26","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/abbs\/gmq085","volume":"42","author":"T Lai","year":"2010","unstructured":"Lai, T., Hou, Q., Yang, H., Luo, X. & Xi, M. Clinical application of a novel sliver nanoparticles biosensor based on localized surface plasmon resonance for detecting the microalbuminuria. Acta Biochim. Biophys. Sin (Shanghai). 42, 787\u2013792 (2010).","journal-title":"Acta Biochim. Biophys. Sin (Shanghai)"},{"key":"44934_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpba.2018.03.060","volume":"155","author":"E Fabini","year":"2018","unstructured":"Fabini, E., Tramarin, A. & Bartolini, M. Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening. J. Pharm. Biomed. Anal. 155, 177\u2013184 (2018).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"44934_CR28","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpba.2016.01.051","volume":"122","author":"E Fabini","year":"2016","unstructured":"Fabini, E., Fiori, G. M. L., Tedesco, D., Lopes, N. P. & Bertucci, C. Surface plasmon resonance and circular dichroism characterization of cucurbitacins binding to serum albumins for early pharmacokinetic profiling. J. Pharm. Biomed. Anal. 122, 166\u2013172 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"44934_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.15171\/bi.2017.12","volume":"7","author":"M Sharifi","year":"2017","unstructured":"Sharifi, M. et al. Surface plasmon resonance and molecular docking studies of bovine serum albumin interaction with neomycin: Kinetic and thermodynamic analysis. BioImpacts 7, 91\u201397 (2017).","journal-title":"BioImpacts"},{"key":"44934_CR30","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2116\/analsci.31.1255","volume":"31","author":"R Onishi","year":"2015","unstructured":"Onishi, R. et al. Surface plasmon resonance assay of binding properties of antisense oligonucleotides to serum albumins and lipoproteins. Anal. Sci. 31, 1255\u20131260 (2015).","journal-title":"Anal. Sci."},{"key":"44934_CR31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jpba.2017.03.054","volume":"144","author":"E Fabini","year":"2017","unstructured":"Fabini, E. & Danielson, U. H. Monitoring drug\u2013serum protein interactions for early ADME prediction through Surface Plasmon Resonance technology. J. Pharm. Biomed. Anal. 144, 188\u2013194 (2017).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"44934_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep35987","volume":"6","author":"M Baldassarre","year":"2016","unstructured":"Baldassarre, M. et al. Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule. Sci. Rep. 6, 1\u20139 (2016).","journal-title":"Sci. Rep."},{"key":"44934_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/ars.2016.6664","volume":"25","author":"JC Jha","year":"2016","unstructured":"Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E. & Jandeleit-Dahm, K. Diabetes and kidney disease: Role of oxidative stress. Antioxid. Redox Signal. 25, 657\u2013684 (2016).","journal-title":"Antioxid. Redox Signal."},{"key":"44934_CR34","doi-asserted-by":"crossref","unstructured":"Naldi, M., Baldassarre, M., Domenicali, M., Bartolini, M. & Caraceni, P. Structural and functional integrity of human serum albumin: Analytical approaches and clinical relevance in patients with liver cirrhosis. J Pharm. Biomed. Anal 144 (2017).","DOI":"10.1016\/j.jpba.2017.04.023"},{"key":"44934_CR35","doi-asserted-by":"publisher","unstructured":"de Mol, N. J. & Fischer, M. J. E. Surface plasmon resonance: Methods and protocols. Life Sci. 55\u201373. https:\/\/doi.org\/10.1007\/978-1-60761-670-2 (2010).","DOI":"10.1007\/978-1-60761-670-2"},{"key":"44934_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1255\/ejms.1256","volume":"19","author":"M Naldi","year":"2013","unstructured":"Naldi, M. et al. A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field. Eur. J. Mass. Spectrom. 19, 491\u2013496 (2013).","journal-title":"Eur. J. Mass. Spectrom."},{"key":"44934_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2133\/dmpk.23.120","volume":"23","author":"Y Kuroda","year":"2008","unstructured":"Kuroda, Y., Saito, M., Sakai, H. & Yamaoka, T. Rapid characterization of drug-drug interaction in plasma protein binding using a surface plasmon resonance biosensor. Drug Metab. Pharmacokinet. 23, 120\u2013127 (2008).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"44934_CR38","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/pro.749","volume":"20","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. A fluorescent fatty acid probe, DAUDA, selectively displaces two myristates bound in human serum albumin. Protein Sci. 20, 2095\u20132101 (2011).","journal-title":"Protein Sci."},{"key":"44934_CR39","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1172\/JCI107882","volume":"54","author":"R Brodersen","year":"1974","unstructured":"Brodersen, R. Competitive binding of bilirubin and drugs to human serum albumin studied by enzymatic oxidation. J. Clin. Invest. 54, 1353\u20131364 (1974).","journal-title":"J. Clin. Invest."},{"key":"44934_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jps.10293","volume":"9","author":"YSN Day","year":"2003","unstructured":"Day, Y. S. N. & Myszka, D. G. Characterizing a drug\u2019s primary binding site on albumin. J. Pharm. Sci. 9, 333\u2013343 (2003).","journal-title":"J. Pharm. Sci."},{"key":"44934_CR41","first-page":"1","volume":"223","author":"KA Bakar","year":"2019","unstructured":"Bakar, K. A. & Feroz, S. R. A critical view on the analysis of fluorescence quenching data for determining ligand\u2013protein binding affinity. Spectrochim Acta - Part. Mol. Biomol. Spectrosc. 223, 1\u20135 (2019).","journal-title":"Spectrochim Acta - Part. Mol. Biomol. Spectrosc."},{"key":"44934_CR42","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00216-008-2427-8","volume":"392","author":"I Goncharova","year":"2008","unstructured":"Goncharova, I. & Urbanov\u00e1, M. Stereoselective bile pigment binding to polypeptides and albumins: A circular dichroism study. Anal. Bioanal Chem. 392, 1355\u20131365 (2008).","journal-title":"Anal. Bioanal Chem."},{"key":"44934_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/hep.28740","volume":"64","author":"J Cl\u00e0ria","year":"2016","unstructured":"Cl\u00e0ria, J. et al. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure. Hepatology 64, 1249\u20131264 (2016).","journal-title":"Hepatology"},{"key":"44934_CR44","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1002\/hep.31798","volume":"74","author":"M Baldassarre","year":"2021","unstructured":"Baldassarre, M. et al. Determination of effective albumin in patients with decompensated cirrhosis: Clinical and prognostic implications. Hepatology 74, 2058\u20132073 (2021).","journal-title":"Hepatology"},{"key":"44934_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jpba.2016.01.048","volume":"122","author":"M Naldi","year":"2016","unstructured":"Naldi, M. et al. Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. J. Pharm. Biomed. Anal. 122, 141\u2013147 (2016).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"44934_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF00544566","volume":"33","author":"A Assandri","year":"1987","unstructured":"Assandri, A. & Bernareggi, A. Binding of teicoplanin to human serum albumin. Eur. J. Clin. Pharmacol. 33, 191\u2013195 (1987).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"44934_CR47","first-page":"1","volume":"11","author":"C Zoratti","year":"2022","unstructured":"Zoratti, C. et al. Antibiotics and liver cirrhosis: What the physicians need to know. Antibiotics 11, 1\u201319 (2022).","journal-title":"Antibiotics"},{"key":"44934_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/11539220-000000000-00000","volume":"50","author":"M Ulldemolins","year":"2011","unstructured":"Ulldemolins, M., Roberts, J. A., Rello, J., Paterson, D. L. & Lipman, J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin. Pharmacokinet. 50, 99\u2013110 (2011).","journal-title":"Clin. Pharmacokinet."},{"key":"44934_CR49","first-page":"281","volume":"3","author":"S Prakash","year":"2017","unstructured":"Prakash, S. Role of human serum albumin and oxidative stress in diabetes. J. Appl. Biotechnol. Bioeng. 3, 281\u2013285 (2017).","journal-title":"J. Appl. Biotechnol. Bioeng."},{"key":"44934_CR50","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","volume":"98","author":"K International","year":"2020","unstructured":"International, K. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 98, S1\u2013S115 (2020).","journal-title":"Kidney Int."},{"key":"44934_CR51","first-page":"1280","volume":"7","author":"S Babu Kondaveeti","year":"2013","unstructured":"Babu Kondaveeti, S., Kumaraswamy, D., Mishra, S. & Aravind Kumar, R. Anand Shaker, I. Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus. J. Clin. Diagn. Res. 7, 1280\u20131283 (2013).","journal-title":"J. Clin. Diagn. Res."},{"key":"44934_CR52","unstructured":"Copeland, R. A. A Practical Introduction to Structure, Mechanism, and Data Analysis (Wiley-VCH, 2000)."},{"key":"44934_CR53","unstructured":"Segel, I. H. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (York, Wiley-Interscience: New, 1975)."},{"key":"44934_CR54","unstructured":"Cantor, C. R. & Schimmel, P. R. Biophysical Chemistry; Part III: The Behavior of Biological Macromolecules (W. H. Freeman & Co., 1980)."},{"key":"44934_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/(SICI)1099-1352(199909\/10)12:5<279::AID-JMR473>3.0.CO;2-3","volume":"12","author":"DG Myszka","year":"1999","unstructured":"Myszka, D. G. Improving biosensor analysis. J. Mol. Recognit. 12, 279\u2013284 (1999).","journal-title":"J. Mol. Recognit."},{"key":"44934_CR56","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0009-8981(74)90109-0","volume":"52","author":"CG Beng","year":"1974","unstructured":"Beng, C. G., Rasanayagam, L. J., Lim, K. L. & Lau, K. S. Solubility and absorption spectra of complexes resulting from interaction among human albumin, bromcresol green and detergents. Clin. Chim. Acta. 52, 257\u2013269 (1974).","journal-title":"Clin. Chim. Acta"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44934-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44934-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:12:05Z","timestamp":1774998725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44934-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44934-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7190507\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10920"}}